| 1 |
29076612 | New Insights into SN-38 Glucuronidation: Evidence for the Important Role of UDP Glucuronosyltransferase 1A9. | 2018 Apr |
4 |
| 2 |
27895797 | UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. | 2016 Nov |
1 |
| 3 |
24897286 | Association analysis of UGT1A genotype and haplotype with SN-38 glucuronidation in human livers. | 2014 Apr |
6 |
| 4 |
23303296 | Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy. | 2013 Feb |
1 |
| 5 |
23789755 | [Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G]. | 2013 Mar-Apr |
5 |
| 6 |
24033692 | UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. | 2013 Dec |
1 |
| 7 |
21617725 | Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer. | 2011 Mar-Apr |
2 |
| 8 |
18221820 | Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. | 2009 Jan |
1 |
| 9 |
18981166 | Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in Japanese. | 2009 Feb |
3 |
| 10 |
17700594 | Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients. | 2008 Jun |
5 |
| 11 |
18418374 | Pharmacogenetic pathway analysis of irinotecan. | 2008 Sep |
6 |
| 12 |
18816295 | Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9). | 2008 Aug |
2 |
| 13 |
17406868 | Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer. | 2007 Sep |
3 |
| 14 |
17608024 | UGT1AI*6 and UGT1A1*27 for individualized irinotecan chemotherapy. | 2007 Jun |
1 |
| 15 |
16595709 | The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver. | 2006 Jul |
6 |
| 16 |
16636344 | Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. | 2006 May 20 |
2 |
| 17 |
15709193 | UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. | 2005 Feb 1 |
2 |
| 18 |
15864130 | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 2005 May |
4 |
| 19 |
15286088 | Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. | 2004 Aug |
6 |
| 20 |
12730278 | Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. | 2003 Aug |
4 |
| 21 |
12181437 | Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). | 2002 Sep |
4 |
| 22 |
11695848 | Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin. | 2001 Oct |
2 |